EUCTR2006-001217-15-FI进行中（未招募）不适用
PRO-FEIBA. Asetelma on selkeä etenevä satunnaistettu kaksisuuntainen tutkimus aktivoitujen hyytymistekijöiden (aPCC, activated prothrombin complex concentrate) vaikutuksesta vaikeaa A hemofiliaa sairastavien miesten taudinkulkuun, elämänlaatuun ja terveystaloudellisiin näkökohtiin.
assila Riitta0 个研究点目标入组 42 人开始时间: 2006年2月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
FEIBA NF: A PROSPECTIVE, OPEN-LABEL, RANDOMIZED, PARALLEL STUDY TO EVALUATE EFFICACY AND SAFETY OF PROPHYLACTIC VERSUS ON-DEMAND TREATMENT IN SUBJECTS WITH HEMOPHILIA A OR B AND A HIGH TITER INHIBITORHemophilia A or B and a high titer inhibitorMedDRA version: 12.1Level: LLTClassification code 10053751Term: Hemophilia A with anti factor VIIIMedDRA version: 12.1Level: LLTClassification code 10053752Term: Hemophilia B with anti factor IXEUCTR2008-003855-65-PLBaxter Innovations GmbH34
进行中（未招募）
不适用
FEIBA NF: STUDIO PROSPETTICO IN APERTO, RANDOMIZZATO, A GRUPPI PARALLELI, VOLTO A VALUTARE EFFICACIA E SICUREZZA DEL TRATTAMENTO PROFILATTICO VS QUELLO AL BISOGNO IN PAZIENTI AFFETTI DA EMOFILIA A O B E CON INIBITORI A TITOLO ELEVATO - FEIBA NF Prophylaxis StudyHemophilia A or B and a high titer inhibitorMedDRA version: 9.1Level: LLTClassification code 10063563EUCTR2008-003855-65-ITBAXTER INNOVATIONS GMBH34
进行中（未招募）
1 期
FEIBA NF: A prospective, open-label, randomized, parallel study to evaluate efficacy and safety of prophylactic versus on-demand treatment in subjects with hemophilia A or B and a high titer inhibitor - FEIBA NF Prophylaxis StudyHemophilia A or B and a high titer inhibitorMedDRA version: 9.1 Level: LLT Classification code 10056492 Term: Haemophilia A with anti factor VIIIMedDRA version: 9.1 Level: LLT Classification code 10056494 Term: Haemophilia B with anti factor IXEUCTR2008-003855-65-FRBaxter Innovations GmbH36
进行中（未招募）
不适用
FEIBA NF: A prospective, open-label, randomized, parallel study to evaluate efficacy and safety of prophylactic versus on-demand treatment in subjects with hemophilia A or B and a high titer inhibitor - FEIBA NF Prophylaxis StudyEUCTR2008-003855-65-BGBaxter Innovations GmbH34
尚未招募
不适用
Evaluating the Safety And Effectiveness of the Valet Micro CatheterCoronary Artery Disease (CAD)Peripheral Artery Disease (PAD)Cardiovascular - Coronary heart diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12612000009819Volcano Corporation15